BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/14/2018 5:07:58 AM | Browse: 945 | Download: 1214
Publication Name World Journal of Gastroenterology
Manuscript ID 36845
Country/Territory Italy
Received
2017-10-27 00:33
Peer-Review Started
2017-10-27 08:07
To Make the First Decision
2017-11-22 00:58
Return for Revision
2017-11-27 09:22
Revised
2017-12-16 08:23
Second Decision
2017-12-19 11:09
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2017-12-20 02:21
Articles in Press
2017-12-20 02:21
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2018-01-08 07:29
Publish the Manuscript Online
2018-01-14 05:07
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Minireviews
Article Title Drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma: Current state of the art
Manuscript Source Invited Manuscript
All Author List Antonio Facciorusso
ORCID
Author(s) ORCID Number
Antonio Facciorusso http://orcid.org/0000-0002-2107-2156
Funding Agency and Grant Number
Corresponding Author Antonio Facciorusso, MD, PhD, Assistant Professor, Gastroenterology Unit, Department of Medical Sciences, University of Foggia, Viale L.Pinto 1, Foggia 71122, Italy. antonio.facciorusso@virgilio.it
Key Words Embolization; Doxorubicin; Conventional; Hepatocarcinoma; Liver cancer; Survival
Core Tip Aim of this review is to summarize the main characteristics and the clinical results of drug-eluting beads (DEB)-transarterial chemoembolization (TACE). To obviate to the limitations of cTACE, non-absorbable embolic microspheres charged with cytotoxic agents (DEBs) have been developed. DEBs are able to simultaneously exert both the therapeutic components of TACE, either drug-carrier function and embolization. This way, risk of systemic drug release is minimal. However, despite promising results of preliminary studies, clear evidence of superiority of DEB-TACE over cTACE is still lacking. In absence of well-designed randomized-controlled trials, the decision on whether use DEB-TACE or cTACE is still controversial.
Publish Date 2018-01-14 05:07
Citation Facciorusso A. Drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma: Current state of the art. World J Gastroenterol 2018; 24(2): 161-169
URL http://www.wjgnet.com/1007-9327/full/v24/i2/161.htm
DOI http://dx.doi.org/10.3748/wjg.v24.i2.161
Full Article (PDF) WJG-24-161.pdf
Full Article (Word) WJG-24-161.doc
Manuscript File 36845-Review.docx
Answering Reviewers 36845-Answering reviewers.pdf
Audio Core Tip 36845-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 36845-Conflict-of-interest statement.pdf
Copyright License Agreement 36845-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate 36845-Language certificate.pdf
Peer-review Report 36845-Peer-review(s).pdf
Scientific Misconduct Check 36845-Scientific misconduct check.pdf
Scientific Editor Work List 36845-Scientific editor work list.pdf